Add to Favorites Newsroom RSS Share
fb-shareJoslin Diabetes Center
Boston, MA USA

Our News on Newswise

Artificial pancreas system better controls blood glucose levels than current technology

A multi-center randomized clinical trial evaluating a new artificial pancreas system — which automatically monitors and regulates blood glucose levels — has found that the new system was more effective than existing treatments at controlling...
16-Oct-2019 8:05 PM EDT Add to Favorites

The diabetes pandemic and the promise of connected care

Digital diabetes management systems (“connected diabetes care”) have the potential to become part of a new diabetes care model, augmenting the traditional practice of diabetes care by providing continuous and on-demand assistance that aligns...
3-Oct-2019 10:05 AM EDT Add to Favorites

High-fructose + high-fat diet damages mitochondria in the liver increasing risk of fatty-liver disease and metabolic syndrome

BOSTON – (October 1, 2019) – Researchers at Joslin Diabetes Center have found that high levels of fructose in the diet inhibit the liver’s ability to properly metabolize fat. This effect is specific to fructose. Indeed, equally high levels of...
1-Oct-2019 11:05 AM EDT Add to Favorites

Discovery enables clear identification of diseased beta cells in type 2 diabetes

BOSTON – (July 29, 2019) – Researchers at Joslin Diabetes Center, an affiliate of Harvard Medical School, have unlocked the key to clearly identifying diseased beta cells in type 2 diabetes. This discovery has both research and therapeutic...
29-Jul-2019 11:05 AM EDT Add to Favorites

Newswise: AnnLagasse.jpg

Ann Lagasse Elected to Chair of Board of Trustees

Ann Lagasse, principal at Ocean's Havens, LLC, of Newburyport, MA, has been elected to be the next chair of the Joslin Diabetes Center Board of Trustees.
10-Jul-2019 3:05 PM EDT Add to Favorites

Newswise: Marty_Pasqualini-a.jpg

Martin Pasqualini Elected to Joslin Diabetes Center Board of Trustees

Martin Pasqualini, Managing Director of the CGA Group, has been elected to the Board of Trustees of Joslin Diabetes Center, an affiliate of Harvard Medical School.
10-Jul-2019 10:05 AM EDT Add to Favorites

Newswise: Dacey_headshot.jpg

Susan Dacey Elected to Joslin Diabetes Center Board of Trustees

Susan Dacey, CEO and Chair of the Board of Directors for Industrial Polymers and Chemicals, Inc. has been elected to the Joslin Board of Trustees.
10-Jul-2019 10:05 AM EDT Add to Favorites

Newswise: TAbbrecht3CroppedSmallNEWJanuary2019.jpg

Todd Abbrecht Elected to Joslin Diabetes Center Board of Trustees

Todd Abbrecht, Head of Private Equity at Thomas H. Lee Partners, has been elected to its Board of Trustees of the Joslin Diabetes Center, an affiliate of Harvard Medical School.
10-Jul-2019 10:05 AM EDT Add to Favorites


see all news

Our Experts on Newswise

Diabetes & Breast Cancer - Elizabeth Halprin MD Talks About the Important Struggle to Balance Both Diseases

12-Oct-2017 10:05 AM EDT

Newswise: Laffel21.jpg

Dr. Lori Laffel, Chief of Pediatrics at Joslin Diabetes Center, Available to Comment on Type 1 Diabetes and Life Expectancy Studies

6-Jan-2015 11:00 AM EST

Newswise: laffel28.jpg

Back to School with Dr. Lori Laffel from Joslin Diabetes Center

Lori Laffel, M.D., MPH, Chief of the Pediatric, Adolescent and Young Adult Section at Joslin Diabetes Center and Associate Professor of Pediatrics at Harvard Medical School, oversees the largest pediatric diabetes clinic in New England has over 25...
15-Aug-2014 8:00 AM EDT

Expert Available: Bariatric Surgery for Diabetes

The International Diabetes Federation now recommends that surgery be considered as a treatment for obese patients with type 2 diabetes. Dr. Allison Goldfine, head of clinical research at Joslin Diabetes Center, is available for comment.
29-Mar-2011 9:00 AM EDT

see all experts

Our YouTube Videos

About

Joslin Diabetes Center is world-renowned for its deep expertise in diabetes treatment and research. Joslin is dedicated to finding a cure for diabetes and ensuring that people with diabetes live long, healthy lives. We develop and disseminate innovative patient therapies and scientific discoveries throughout the world. Joslin is an independent, non-profit institution affiliated with Harvard Medical School, and one of only 16 NIH-designated Diabetes Research Centers in the U.S.

For more information, visit www.joslin.org or follow @joslindiabetes

Contacts

Jeffrey Bright
Director, Communications

jeffrey.bright@joslin.harvard.edu

617-309-1957

Twitter twitter-icon

Chat now!
0.82542